Clinical Trial Update: Pharmacogenetics of Naltrexone for Stimulant Abuse [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pharmacogenetics of naltrexone for stimulant abuse has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methamphetamine Abuse
• Substance Use Disorders

Drugs mentioned

• Naltrexone (Naltrexone)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Substance Use Disorders, Methamphetamine Abuse | Phase 2 | Status: COMPLETED | Results posted: 2020-10-26